Tau pathology in triple knock‐in mouse model of Alzheimer's Disease expressing APOE3 and APOE4

The results of this project demonstrate that tau pathology markers appear to increase as a function of age, APOE4 and the ability to accumulate insoluble Abeta and plaques<sup>.</sup> These results agree with the notion that amyloid and APOE4 can increase tau markers even in less aggressive animal models without tau overexpression or mutations. Our findings also suggest that there are no genotype-dependent differences in learning and memory in the PAL task at early ages, despite these mice presenting other cognitive deficits at that stage.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_101626
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tau pathology in triple knock‐in mouse model of Alzheimer's Disease expressing APOE3 and APOE4

Mark Longmuir, Vânia F. Prado, Timothy J. Bussey, Aya Arrar et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Tau pathology in triple knock‐in mouse model of Alzheimer's Disease expressing APOE3 and APOE4

Mark Longmuir, Vânia F. Prado, Timothy J. Bussey, Aya Arrar, Lisa M Saksida, Taylor W. Schmitz, Marco AM Prado, Jamie L Fournier
article en

Abstract

The results of this project demonstrate that tau pathology markers appear to increase as a function of age, APOE4 and the ability to accumulate insoluble Abeta and plaques<sup>.</sup> These results agree with the notion that amyloid and APOE4 can increase tau markers even in less aggressive animal models without tau overexpression or mutations. Our findings also suggest that there are no genotype-dependent differences in learning and memory in the PAL task at early ages, despite these mice presenting other cognitive deficits at that stage.

Alzheimer s & DementiaVol. 21(S1)
Western University (CA), Robarts Clinical Trials (CA)
Openalex Percentile: Top 34%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.